Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Recruiting now · Not applicable

Conditions studied: Gynecologic Cancer, Hereditary Cancer Syndrome

In brief

In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.

Key facts

Study ID: NCT05562778
Run by: Weill Medical College of Cornell University
People needed: 150
Starts: 2023-01-15
Expected to finish: 2027-12-01
Last updated by the study team: 2026-06-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

8 years of age or older.
Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
Access to a telephone with texting capacity.
Has not had prior genetic testing for hereditary cancer syndromes.

You may not qualify if…

Under 18 years of age
Has had previous genetic testing for hereditary cancer syndromes
Does not read/speak in English
Does not have access to a phone with texting capabilities

Where it is running

NYP Brooklyn Methodist Hospital — Brooklyn, New York, United States (enrolling)
NYP Lower Manhattan Hospital — New York, New York, United States (enrolling)
Weill Cornell Medicine — New York, New York, United States (enrolling)
NYP Medical Group Queens — Queens, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.